Patents by Inventor Karen M. Oxenb.o slashed.ll

Karen M. Oxenb.o slashed.ll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Purified myceliophthora laccases and nucleic acids encoding same
    Patent number: 5981243
    Abstract: The present invention relates to isolated nucleic acid constructs containing a sequence encoding a Myceliophthora laccase, and the laccase proteins encoded thereby.
    Type: Grant
    Filed: September 29, 1997
    Date of Patent: November 9, 1999
    Inventors: Randy Michael Berka, Stephen H. Brown, Feng Xu, Palle Schneider, Karen M. Oxenb.o slashed.ll, Dorrit A. Aaslyng
  • Glucose oxidases obtained from a cladosporium
    Patent number: 5834280
    Abstract: The invention is directed to alkaline glucose oxidases comprising novel peptide sequences obtained from a strain of Cladosporium, particulary Cladosporium oxysporum, strain CBS 163.94. Furthermore, the invention relates to methods for producing and using said glucose oxidases.
    Type: Grant
    Filed: November 7, 1996
    Date of Patent: November 10, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Karen M. Oxenb.o slashed.ll, Joan Qi Si, Jesper Aagaard
  • Purified Myceliophthora laccases and nucleic acids encoding same
    Patent number: 5795760
    Abstract: The present invention relates to isolated nucleic acid constructs containing a sequence encoding a Myceliophthora laccase, and the laccase proteins encoded thereby.
    Type: Grant
    Filed: September 29, 1997
    Date of Patent: August 18, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Randy Michael Berka, Stephen H. Brown, Feng Xu, Palle Schneider, Karen M. Oxenb.o slashed.ll, Dorrit A. Aaslyng
  • Alkaline glucose oxidase obtained from cladosporium oxysporum
    Patent number: 5741688
    Abstract: A glucose oxidase obtained from a Cladosporium oxysporum strain, designated as CBS 163.94, characterized by a pH-optimum in he range pH 6-7, having more than 75% of maximum activity at pH 8, determined at 30.degree. C. with D-glucose as substrate.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: April 21, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Karen M. Oxenb.o slashed.ll, Joan Qi Si, Jesper Aagaard